{"id":"NCT00090051","sponsor":"Hoffmann-La Roche","briefTitle":"FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients","officialTitle":"Open-label, Multicenter, Randomized, Comparative, Phase III Study to Evaluate the Efficacy and Safety of FCR vs. FC Alone in Previously Treated Patients With CD20 Positive B-cell CLL","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-07-31","primaryCompletion":"2008-07-23","completion":"2012-05-31","firstPosted":"2004-08-25","resultsPosted":"2012-01-23","lastUpdate":"2017-08-01"},"enrollment":552,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Lymphocytic Leukemia"],"interventions":[{"type":"DRUG","name":"Rituximab","otherNames":[]},{"type":"DRUG","name":"Fludarabine Phosphate","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]}],"arms":[{"label":"Fludarabine+Cyclophosphamide (FC)","type":"ACTIVE_COMPARATOR"},{"label":"Fludarabine+Cyclophosphamide+Rituximab (FCR)","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to provide treatment for patients who have chronic lymphocytic leukemia (CLL), and to compare the use of rituximab added to fludarabine+cyclophosphamide (FC) with FC alone, to determine if rituximab lengthens the time a patient remains free of leukemia symptoms.","primaryOutcome":{"measure":"Progression-free Survival (PFS) as Assessed by the Independent Review Committee (IRC)","timeFrame":"Mean observation time at time of analysis was approximately 26 months","effectByArm":[{"arm":"Fludarabine+Cyclophosphamide (FC)","deltaMin":660,"sd":null},{"arm":"Fludarabine+Cyclophosphamide+Rituximab (FCR)","deltaMin":813,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0218"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":17},"locations":{"siteCount":106,"countries":["United States","Australia","Belgium","Canada","Denmark","France","Hungary","Italy","Netherlands","New Zealand","Norway","Poland","Romania","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["24916506","23525797"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":132,"n":272},"commonTop":["Neutropenia","Nausea","Vomiting","Anaemia","Pyrexia"]}}